Produktinformation
- Hydrazinecarboxamide, N-(2,6-dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-
- N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazinecarboxamide
JTE 013 is a medicinal compound that acts as an inhibitor of kinases, which are enzymes involved in cell cycle regulation and tumor growth. It has been shown to induce apoptosis, or programmed cell death, in cancer cells and has potential as an anticancer agent. JTE 013 has been tested on human cancer cell lines and found to be effective at inhibiting protein expression related to the growth of tumors. This compound has also been found in urine samples of Chinese patients with various forms of cancer, indicating its potential for use as a diagnostic tool. Overall, JTE 013 shows promise as a potent inhibitor of kinases for use in the treatment of cancer.
Chemische Eigenschaften
Technische Anfrage zu: 3D-XWA75693 JTE 013
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
